Health
Diabetes treatment may protect against COVID-19 mortality – Medical News Today
A study involving a diverse patient population suggests that a diabetes drug, metformin, may help reduce the risk of COVID-19 mortality.
A critical area of COVID-19 research has focused on the risk factors that may make a person more likely to either get a SARS-CoV-2 infection or die from COVID-19 if they develop it.
SARS-CoV-2 is a novel coronavirus, and while it bears some similarities to other coronaviruses, there is still much that researchers are yet to uncover about how and why it affects some people more than others and how to mitigate the risks.
Studies have begun to emerge demonstrating associations between specific health…
-
Noosa News21 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business24 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News23 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General22 hours agoInternal Revenue Service starts cutting 20,000 workers